A corrective and preventive action (CAPA) can be marked complete after a procedure, training program, or design change is implemented—even if no one has shown that the change corrected the cause of the failure. The essential distinction is between doing the planned action and demonstrating that it worked. FDA warning letters illustrate how an effectiveness check can fall short even when a company reports a passing result.
What CAPA closure is supposed to establish
A CAPA process identifies a quality problem, investigates its cause, assigns and implements actions, and checks whether those actions were effective. Implementation evidence might show that a procedure was revised or that employees completed training. That proves the task happened; it does not, by itself, prove the original failure mechanism was addressed or that similar problems stopped occurring.
As an Amazon Associate I earn from qualifying purchases.
FDA inspection guidance directs inspectors to assess whether actions were effective and whether similar problems occurred after implementation. In practice, an effectiveness check should connect the action to the failure it was meant to prevent: it needs to examine the relevant outcome in the people, products, processes, and conditions where the problem can arise. The guidance does not establish one universal statistical method, observation period, or closure formula for every CAPA. FDA CAPA inspection guidance
How a passing check can miss the cause
An effectiveness measure can produce a passing result while failing to test the most important question: did the action address the cause of the problem? This can happen when the measure checks completion or knowledge in a convenient sample, rather than whether the failure recurs under representative conditions. It can also happen when an investigation treats one plausible cause as settled without distinguishing it from other explanations that would require different actions.
#1 Best Overall
Beta Bionics: training results did not resolve a design question
In a warning letter dated January 28, 2026, FDA criticized Beta Bionics’ CAPA 0050 for the iLet Bionic Pancreas System. The company reported a 100% pass rate in an assessment using employees and revised training materials. FDA nevertheless found the verification-of-effectiveness check inadequate: employees were not representative of the actual iLet user population, and the criteria did not distinguish potential system-design issues from user-training deficiencies. The resulting preventive actions focused on training without addressing potential design issues.
FDA’s finding was not that the reported assessment score was false; it was that the check did not establish effectiveness against the relevant problem and possible causes. FDA’s Beta Bionics warning letter
Rank #2
![DeskFX Free Audio Effects & Audio Enhancer Software [PC Download]](https://m.media-amazon.com/images/I/41fXbDohyuS._SL160_.jpg)
- Transform audio playing via your speakers and headphones
- Improve sound quality by adjusting it with effects
- Take control over the sound playing through audio hardware
ZIIP: a document change was not evidence of effectiveness
In a warning letter dated May 22, 2026, FDA said ZIIP closed CAPA 33 on the same day a document change notice was issued for revised complaint procedures, without documented verification that the change was effective. The letter also described other CAPAs whose effectiveness-check fields lacked documentation. Recording a revised procedure establishes that a change was made; without follow-up evidence, it does not establish that the change worked. FDA’s ZIIP warning letter
A practical test for an effectiveness check
Use these questions to assess whether a proposed check tests the outcome rather than merely documenting implementation. They are practical deductions from the FDA examples and guidance, not a universal FDA-prescribed checklist.
- Does it measure the original failure mechanism? A training completion record may show that training occurred, but not that the underlying failure no longer occurs.
- Is the sample representative? Check the people, product, process, and operating conditions where the problem can happen—not only a convenient group.
- Could the check pass if it stopped observing the problem? Consider whether the data source or measurement channel could cease producing observations while the stated pass criterion still appears satisfied.
- Are the decision rules defined? Before collecting results, specify the observation window, threshold, responsible owner, and what would trigger escalation or reopening.
- Does the investigation distinguish plausible causes? If design, training, process, or other explanations remain possible, the check should not treat evidence for one as proof that the others have been ruled out.
What the Project Shadow example does—and does not—show
Phillip Linstrum’s Project Shadow post uses the phrase “a CAPA can close without fixing anything” to describe a failure mode: a record may document containment, root-cause work, assigned actions, and implementation verification while an effectiveness check is absent or inadequate. The post frames a reviewer’s question as finding “a CAPA that can close with or without an effectiveness check.” Its argument is consistent with the distinction illustrated by the FDA cases, but the post is an author’s account, not an FDA finding. Phillip Linstrum’s Project Shadow post and discussion
The post describes Project Shadow R1 as beta/prelive and says it is not production authorization or proof of real-world efficacy. Linstrum reports that a synthetic “BLACK floor” was respected in 6 of 10 cases in one smoke test, and reports a 3–10% improvement in personal testing when an optional narrative “Myth” sidecar was used on most tasks. These are author-reported observations; the post does not establish independent validation or generalizable performance. It also calls for a preregistered comparison of the sidecar on and off.
Rank #4
![Free Fling File Transfer Software for Windows [PC Download]](https://m.media-amazon.com/images/I/41Vq6ZqHfjL._SL160_.jpg)
- Intuitive interface of a conventional FTP client
- Easy and Reliable FTP Site Maintenance.
- FTP Automation and Synchronization
What the examples establish
The FDA letters document specific deficiencies at the named firms; they do not establish how common ineffective or undocumented CAPA checks are across industry. Nor do they show that every closed CAPA is ineffective. They do show why closure should not be treated as proof of success unless the record contains evidence that the action was evaluated against the relevant failure and that similar problems were considered after implementation.
Recommended Free Tools
Quick Recap
Best Value
![Express Schedule Free Employee Scheduling Software [PC/Mac Download]](https://m.media-amazon.com/images/I/41yvuCFIVfS._SL160_.jpg)
- Simple shift planning via an easy drag & drop interface
- Add time-off, sick leave, break entries and holidays
- Email schedules directly to your employees
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
